Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.

A wide selection of therapies are available to treat advanced prostate cancer, but the optimal treatment strategy is unknown.

The new indication would also extend Lynparza's lead in prostate cancer over rival PARP inhibitors like Clovis Oncology's Rubraca (rucaparib), GSK's Zejula (niraparib) and Pfizer's Talzenna ...

Research presented at ESMO 2024 could have practice-changing implications for breast, gastrointestinal, genitourinary, and gynecologic cancers.

Rucaparib is recommended, within its marketing authorisation, as an option for the maintenance treatment of relapsed platinum-sensitive high-grade epithelial, ovarian, fallopian tube or primary ...

Patients with advanced pancreatic cancer with BRCA or PALB2 mutations who are sensitive to platinum-based chemotherapy may be candidates for maintenance therapy with rucaparib. News, April 02 ...

Rayne Beau, a lost cat, managed to travel 800 miles back home after vanishing during a camping trip in Yellowstone National Park. Found exhausted in Roseville, California, he was reunited with his ...

Weak CYP2C19 inhibitors, including cimetidine (Tagamet), felbamate (Felbatol), modafinil (Provigil), and rucaparib (Rubraca); and moderate CYP3A4 inhibitors, including aprepitant (Emend ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The Hezbollah leader, Hassan Nasrallah, did not say how his group would respond to attacks on hand-held devices, which killed dozens when pagers and walkie-talkies exploded. By Aaron Boxerman ...